ArticleTranslational cancer research2025
N6-adenosine methyltransferase METTL4 is a potential prognostic biomarker and associates with cell cycle regulation and immune infiltration in glioma.
Shuo Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.